Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Mar 23, 2021 2:35pm
222 Views
Post# 32859417

poor cube testing: Only 20 patients per cube/day

poor cube testing: Only 20 patients per cube/dayThe TRUTH is finally out, 

Number of tests going forward:        30,000 per month (more or less)

Number of cubes:                                    48 (should remain steady at this)

Tests per cube:                                        20  (this explains why most cubes are EMPTY)

Price per test                                           95

Revenue per month:                  $ 2,850,000  USD

Revenue per year:                      34,200,000  USD


We trade at 1 time sale and that price is JUSTIFIED because there is a TRUST ISSUE.

With trusted companies, price could trade at 10 times sale.

Company has to come back and earn the investors trust. 

We will see if what they promised in this webinar is more lies or truth


MPO

<< Previous
Bullboard Posts
Next >>